000 01635 a2200445 4500
005 20250517200258.0
264 0 _c20180823
008 201808s 0 0 eng d
022 _a1791-2431
024 7 _a10.3892/or.2018.6230
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeo, Yun-Soo
245 0 0 _aPolygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer.
_h[electronic resource]
260 _bOncology reports
_cApr 2018
300 _a1702-1710 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCell Cycle Checkpoints
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aPhosphatidylinositol 3-Kinases
_xgenetics
650 0 4 _aPlatycodon
_xchemistry
650 0 4 _aPolyglactin 910
_xadministration & dosage
650 0 4 _aProto-Oncogene Proteins c-akt
_xgenetics
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aKang, Ok-Hwa
700 1 _aKong, Ryong
700 1 _aZhou, Tian
700 1 _aKim, Sang-A
700 1 _aRyu, Shiyong
700 1 _aKim, Hak-Ryul
700 1 _aKwon, Dong-Yeul
773 0 _tOncology reports
_gvol. 39
_gno. 4
_gp. 1702-1710
856 4 0 _uhttps://doi.org/10.3892/or.2018.6230
_zAvailable from publisher's website
999 _c28037110
_d28037110